What is Japan GMP?
In Japan, Good Manufacturing Practice (GMP) for drugs is referred to as Japanese GMP, or J-GMP. Other Japan-specific pharmaceutical/drug quality standards include the following: Good Quality Practice (GQP), Good Vigilance Practice (GVP), Good Clinical Practice (GCP), and Good Post-marketing Study Practice (GPSP).
What is Japan equivalent of FDA?
The pharmaceutical regulatory authority of Japan is the Pharmaceutical and Food Safety Bureau (PFSB) of the MHLW.
Which law in Japan regulates matters necessary for securing the quality efficacy and safety of pharmaceuticals cosmetics and medical devices?
Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. It was originally passed as Pharmaceutical Affairs Act (薬事法, Yakujihō) in 1960, and was renamed current title in 2014. It is often abbreviated to Iyaku-hin Iryō-kiki tō hō (医薬品医療機器等法) or yakki hō (薬機法).
What is a PMDA inspection?
On November 16, 2020, the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) published Notification PMDA/CPE Notification No. The objective of the compliance inspections is to assess compliance to good clinical practices of drugs and regenerative medicines submitted for approval, or in post-marketing stage.
Who regulates medical devices in Japan?
Pharmaceuticals and Medical Devices Agency
1. Regulatory authorities. The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority. It is subordinate to the Ministry of Health, Labour and Welfare (MHLW).
WHO approved drugs in Japan?
Regulatory authority for drug approval in Japan
- Pharmaceuticals and Medical Devices Agency (PMDA), and.
- Ministry of Health, Labour, and Welfare (MHLW).
What is quasi drug Japan?
Definition of Quasi-Drugs Quasi-drugs are products that fall in between cosmetics and pharmaceuticals. On the other hand, quasi-drugs are products with formulations that are recognized and licensed by the Ministry of Health, Labour and Welfare in Japan.